These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33509807)

  • 1. The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer.
    Kim SH; Singh KB; Hahm ER; Singh SV
    Cancer Prev Res (Phila); 2021 Apr; 14(4):421-432. PubMed ID: 33509807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.
    Kim SH; Kaschula CH; Priedigkeit N; Lee AV; Singh SV
    J Biol Chem; 2016 Jun; 291(26):13495-508. PubMed ID: 27129776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells.
    Kim SH; Singh SV
    Cancer Prev Res (Phila); 2014 Jul; 7(7):738-47. PubMed ID: 24824039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mechanistic targets of forkhead box Q1 transcription factor in human breast cancer cells.
    Kim SH; Hahm ER; Singh KB; Singh SV
    Mol Carcinog; 2020 Oct; 59(10):1116-1128. PubMed ID: 32754922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withaferin A inhibits expression of ataxia telangiectasia and Rad3-related kinase and enhances sensitivity of human breast cancer cells to cisplatin.
    Hahm ER; Lee J; Abella T; Singh SV
    Mol Carcinog; 2019 Nov; 58(11):2139-2148. PubMed ID: 31441116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin.
    Antony ML; Lee J; Hahm ER; Kim SH; Marcus AI; Kumari V; Ji X; Yang Z; Vowell CL; Wipf P; Uechi GT; Yates NA; Romero G; Sarkar SN; Singh SV
    J Biol Chem; 2014 Jan; 289(3):1852-65. PubMed ID: 24297176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocarboxylate transporter 1 is a novel target for breast cancer stem like-cell inhibition by diallyl trisulfide.
    Kim SH; Singh SV
    Mol Carcinog; 2022 Aug; 61(8):752-763. PubMed ID: 35512572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.
    Stan SD; Hahm ER; Warin R; Singh SV
    Cancer Res; 2008 Sep; 68(18):7661-9. PubMed ID: 18794155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells.
    Hahm ER; Lee J; Huang Y; Singh SV
    Mol Carcinog; 2011 Aug; 50(8):614-24. PubMed ID: 21432907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.
    Lee J; Hahm ER; Marcus AI; Singh SV
    Mol Carcinog; 2015 Jun; 54(6):417-29. PubMed ID: 24293234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withaferin A-mediated apoptosis in breast cancer cells is associated with alterations in mitochondrial dynamics.
    Sehrawat A; Samanta SK; Hahm ER; St Croix C; Watkins S; Singh SV
    Mitochondrion; 2019 Jul; 47():282-293. PubMed ID: 30685490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-seq reveals novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells.
    Hahm ER; Kim SH; Singh KB; Singh SV
    Mol Carcinog; 2021 Jan; 60(1):3-14. PubMed ID: 33150660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells.
    Lee J; Hahm ER; Singh SV
    Carcinogenesis; 2010 Nov; 31(11):1991-8. PubMed ID: 20724373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Krüppel-like Factor 4-p21
    Kim SH; Singh SV
    Cancer Prev Res (Phila); 2019 Mar; 12(3):125-134. PubMed ID: 30723175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells.
    Lee J; Sehrawat A; Singh SV
    Breast Cancer Res Treat; 2012 Nov; 136(1):45-56. PubMed ID: 22965833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells.
    Sehrawat A; Kim SH; Vogt A; Singh SV
    Carcinogenesis; 2013 Apr; 34(4):864-73. PubMed ID: 23276794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy fails to alter withaferin A-mediated lethality in human breast cancer cells.
    Hahm ER; Singh SV
    Curr Cancer Drug Targets; 2013 Jul; 13(6):640-50. PubMed ID: 23607597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of polycomb group protein Bmi-1 and Notch4 in breast cancer stem cell inhibition by benzyl isothiocyanate.
    Kim SH; Singh SV
    Breast Cancer Res Treat; 2015 Feb; 149(3):681-92. PubMed ID: 25663545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FoxQ1 transcription factor is a novel regulator of electron transport chain complex I subunits in human breast cancer cells.
    Kim SH; Singh SV
    Mol Carcinog; 2022 Mar; 61(3):372-381. PubMed ID: 34939230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells.
    Hahm ER; Lee J; Singh SV
    Mol Carcinog; 2014 Nov; 53(11):907-16. PubMed ID: 24019090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.